Macrophage metabolism in atherosclerosis
- PMID: 28796886
- DOI: 10.1002/1873-3468.12786
Macrophage metabolism in atherosclerosis
Abstract
A key aspect of atherosclerosis is the maladaptive inflammatory response to lipoprotein accumulation in the artery. The failure to decrease lipid accumulation, to clear apoptotic cells, and to resolve inflammation ultimately leads to macrophage accumulation within the vascular wall [Thorp EB (2010) Apoptosis15, 1124-1136; Moore K et al. (2013) Nat Rev Immunol 13, 709-721; Moore KJ and Tabas I (2011) Cell 145, 341-355; Ley K et al. (2011) Arterioscler Thromb Vasc Biol 31, 1506-1516]. Several subsets of macrophages are found inside atherosclerotic plaques [Chinetti-Gbaguidi G et al. (2015) Nat Rev Cardiol 12, 10-17; Leitinger N and Schulman IG (2013) Arterioscler Thromb Vasc Biol 33, 1120-1126; Mantovani A et al. (2009) Arterioscler Thromb Vasc Biol 29, 1419-1423]: Proinflammatory M1-like macrophages potentially participate in atherosclerosis initiation and progression; M2-like macrophages are thought to be protective due to their anti-inflammatory and profibrotic properties, presumably stabilizing the plaque [Chistiakov DA et al. (2015) Int J Cardiol 184, 436-445; Gordon S (2003) Nat Rev Immunol 3, 23-35]; Mox macrophages develop in response to oxidized phospholipids and present a glutathione- and potentially redox-regulating phenotype [Kadl A et al. (2010) Circ Res 107, 737-746]; Mhem macrophages are found in areas of plaque hemorrhage [Boyle JJ et al. (2009) Am J Pathol 174, 1097-1108; Boyle JJ et al. (2012) Circ Res 110, 20-33] where they are involved in heme clearance. Recent evidence suggests that the relative abundance of these macrophage subsets is a better indicator of plaque progression and stability than the total number of lesion macrophages [Chinetti-Gbaguidi G et al. (2015) Nat Rev Cardiol 12, 10-17]. Over the last few years, findings in the area of immunometabolism established a link between the metabolic state of the different macrophage phenotypes and their functions [O'Neill LAJ and Pearce EJ (2016) J Exp Med 213, 15-23]. However, the effect of metabolic changes in macrophages on atherosclerotic plaque progression and stability is not well understood and an area of intensive study. In this review, we will summarize and critically discuss recent developments in the field of macrophage metabolism in the context of atherosclerosis to guide future investigation in this area.
Keywords: atherosclerosis; macrophage; metabolism.
© 2017 Federation of European Biochemical Societies.
Similar articles
-
Macrophage phenotypes in atherosclerosis.Immunol Rev. 2014 Nov;262(1):153-66. doi: 10.1111/imr.12218. Immunol Rev. 2014. PMID: 25319333 Review.
-
Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy.Heart Fail Rev. 2019 May;24(3):399-409. doi: 10.1007/s10741-018-09764-z. Heart Fail Rev. 2019. PMID: 30673930 Review.
-
Pathophysiological relevance of macrophage subsets in atherogenesis.Thromb Haemost. 2017 Jan 5;117(1):7-18. doi: 10.1160/TH16-08-0593. Epub 2016 Sep 29. Thromb Haemost. 2017. PMID: 27683760 Review.
-
[Macrophage activation in atherosclerosis. Message 1: Activation of macrophages normally and in atherosclerotic lesions].Patol Fiziol Eksp Ter. 2015 Jul-Sep;(3):128-31. Patol Fiziol Eksp Ter. 2015. PMID: 26852607 Review. Russian.
-
Targeting Macrophage Phenotypes and Metabolism as Novel Therapeutic Approaches in Atherosclerosis and Related Cardiovascular Diseases.Curr Atheroscler Rep. 2024 Oct;26(10):573-588. doi: 10.1007/s11883-024-01229-z. Epub 2024 Aug 12. Curr Atheroscler Rep. 2024. PMID: 39133247 Free PMC article. Review.
Cited by
-
Superior antitumor immune response achieved with proton over photon immunoradiotherapy is amplified by the nanoradioenhancer NBTXR3.J Nanobiotechnology. 2024 Oct 1;22(1):597. doi: 10.1186/s12951-024-02855-0. J Nanobiotechnology. 2024. PMID: 39354474 Free PMC article.
-
Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation.Curr Neuropharmacol. 2020;18(11):1064-1075. doi: 10.2174/1570159X17666191118125018. Curr Neuropharmacol. 2020. PMID: 31744449 Free PMC article. Review.
-
The Cholinergic Anti-Inflammatory Pathway Attenuates the Development of Atherosclerosis in Apoe-/- Mice through Modulating Macrophage Functions.Biomedicines. 2021 Sep 3;9(9):1150. doi: 10.3390/biomedicines9091150. Biomedicines. 2021. PMID: 34572339 Free PMC article.
-
Monocytes and macrophages in atherogenesis.Curr Opin Lipidol. 2019 Oct;30(5):401-408. doi: 10.1097/MOL.0000000000000634. Curr Opin Lipidol. 2019. PMID: 31361625 Free PMC article. Review.
-
Endocytic Adaptors in Cardiovascular Disease.Front Cell Dev Biol. 2020 Dec 11;8:624159. doi: 10.3389/fcell.2020.624159. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33363178 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical